Industry response to the Spanish governmental Plan for the Promotion of R&D within the Pharmaceutical Industry (1986-1996).
- Published in:
- Science & Public Policy (SPP), 2004, v. 31, n. 4, p. 301
- By:
- Publication type:
- Article
Works by Escolano, Isabel Pérez
Results: 4
1
2
Lifetime Health Consequences and Cost-effectiveness of Rosiglitazone in Combination with Metformin for the Treatment of Type 2 Diabetes in Spain.
- Published in:
- PharmacoEconomics, 2006, p. 49, doi. 10.2165/00019053-200624001-00005
- By:
- Publication type:
- Article
3
Lifetime health consequences and cost-effectiveness of rosiglitazone in combination with metformin for the treatment of type 2 diabetes in Spain.
- Published in:
- 2006
- By:
- Publication type:
- journal article
4
Long-term clinical impact of introducing a human papillomavirus 16/18 AS04 adjuvant cervical cancer vaccine in Spain.
- Published in:
- European Journal of Public Health, 2008, v. 18, n. 6, p. 674, doi. 10.1093/eurpub/ckn064
- By:
- Publication type:
- Article